Cargando…

Risk of Cardiovascular Diseases Associated With Medications Used in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-analysis

IMPORTANCE: Use of attention-deficit/hyperactivity disorder (ADHD) medications has increased substantially over the past decades, but there are concerns regarding their cardiovascular safety. OBJECTIVE: To provide an updated synthesis of evidence on whether ADHD medications are associated with the r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Le, Yao, Honghui, Li, Lin, Du Rietz, Ebba, Andell, Pontus, Garcia-Argibay, Miguel, D’Onofrio, Brian M., Cortese, Samuele, Larsson, Henrik, Chang, Zheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685490/ https://www.ncbi.nlm.nih.gov/pubmed/36416824 http://dx.doi.org/10.1001/jamanetworkopen.2022.43597

Ejemplares similares

Cardiovascular risk factors in attention‐deficit/hyperactivity disorder: A family design study of Swedish conscripts
por: Garcia‐Argibay, Miguel, et al.
Publicado: (2022)

Attention‐deficit/hyperactivity disorder is associated with increased risk of cardiovascular diseases: A systematic review and meta‐analysis
por: Li, Lin, et al.
Publicado: (2023)

Attention-deficit/hyperactivity disorder as a risk factor for dementia and mild cognitive impairment: A population-based register study
por: Dobrosavljevic, Maja, et al.
Publicado: (2021)

Predicting childhood and adolescent attention-deficit/hyperactivity disorder onset: a nationwide deep learning approach
por: Garcia-Argibay, Miguel, et al.
Publicado: (2022)

Prevalence of sleep disorder diagnoses and sleep medication prescriptions in individuals with ADHD across the lifespan: a Swedish nationwide register-based study
por: Ahlberg, Rickard, et al.
Publicado: (2023)

Risk prediction model for cardiovascular diseases in adults initiating pharmacological treatment for attention-deficit/hyperactivity disorder
por: Dobrosavljevic, Maja, et al.
Publicado: (2022)

Association Between Pharmacological Treatment of Attention-Deficit/Hyperactivity Disorder and Long-term Unemployment Among Working-Age Individuals in Sweden
por: Li, Lin, et al.
Publicado: (2022)

Attention-deficit/hyperactivity disorder symptoms and subsequent cardiometabolic disorders in adults: investigating underlying mechanisms using a longitudinal twin study
por: Dobrosavljevic, Maja, et al.
Publicado: (2023)

Drug treatment for attention-deficit/hyperactivity disorder and suicidal behaviour: register based study
por: Chen, Qi, et al.
Publicado: (2014)

Attention-Deficit/Hyperactivity Disorder (ADHD) and Obesity: Update 2016
por: Cortese, Samuele, et al.
Publicado: (2017)

Association of Polygenic Risk for Attention-Deficit/Hyperactivity Disorder With Co-occurring Traits and Disorders
por: Du Rietz, Ebba, et al.
Publicado: (2018)

Maternal pre-pregnancy overweight/obesity and the risk of attention-deficit/hyperactivity disorder in offspring: a systematic review, meta-analysis and quasi-experimental family-based study
por: Li, Lin, et al.
Publicado: (2020)

Attention-deficit/hyperactivity disorder and smoking habits in pregnant women
por: Andersson, Anneli, et al.
Publicado: (2020)

Genetics of attention deficit hyperactivity disorder
por: Faraone, Stephen V., et al.
Publicado: (2018)

Adult Attention-Deficit/Hyperactivity Disorder and the Risk of Dementia
por: Levine, Stephen Z., et al.
Publicado: (2023)

Attention-Deficit/Hyperactivity Disorder in Looked-After Children: a Systematic Review of the Literature
por: Willis, Renece, et al.
Publicado: (2017)

Attention-Deficit/Hyperactivity Disorder and Mortality Risk in Taiwan
por: Chen, Vincent Chin-Hung, et al.
Publicado: (2019)

Attention-deficit/hyperactivity disorder and occupational outcomes: The role of educational attainment, comorbid developmental disorders, and intellectual disability
por: Jangmo, Andreas, et al.
Publicado: (2021)

Antipsychotic Treatment Among Youths With Attention-Deficit/Hyperactivity Disorder
por: Sultan, Ryan S., et al.
Publicado: (2019)

Psychiatric Comorbidities and Schizophrenia in Youths With Attention-Deficit/Hyperactivity Disorder
por: Jeon, Soo Min, et al.
Publicado: (2023)

Sex Differences in Mental Health Problems and Psychiatric Hospitalization in Autistic Young Adults
por: Martini, Miriam I., et al.
Publicado: (2022)

Mapping phenotypic and aetiological associations between ADHD and physical conditions in adulthood in Sweden: a genetically informed register study
por: Du Rietz, Ebba, et al.
Publicado: (2021)

Polygenic risk scores and early manifestations of attention‐deficit/hyperactivity disorder
por: Larsson, Henrik, et al.
Publicado: (2022)

Association of Perinatal and Childhood Ischemic Stroke With Attention-Deficit/Hyperactivity Disorder
por: Bolk, Jenny, et al.
Publicado: (2022)

Association of Attention-Deficit/Hyperactivity Disorder Diagnosis With Adolescent Quality of Life
por: Kazda, Luise, et al.
Publicado: (2022)

Medications for attention-deficit/hyperactivity disorder in individuals with or without coexisting autism spectrum disorder: analysis of data from the Swedish prescribed drug register
por: Johansson, Viktoria, et al.
Publicado: (2020)

Regional analysis of UK primary care prescribing and adult service referrals for young people with attention-deficit hyperactivity disorder: from little to very little
por: Cortese, Samuele
Publicado: (2020)

Attention-deficit/hyperactivity disorder and impairment in executive functions: a barrier to weight loss in individuals with obesity?
por: Cortese, Samuele, et al.
Publicado: (2013)

Evaluation of Attention-Deficit/Hyperactivity Disorder Medications, Externalizing Symptoms, and Suicidality in Children
por: Shoval, Gal, et al.
Publicado: (2021)

Comparative cardiovascular side effects of medications for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis
por: Lannes, Alice, et al.
Publicado: (2022)

The association between attention-deficit/hyperactivity (ADHD) symptoms and self-employment
por: Verheul, Ingrid, et al.
Publicado: (2016)

Association of Genetic and Environmental Risks for Attention-Deficit/Hyperactivity Disorder With Hypomanic Symptoms in Youths
por: Hosang, Georgina M., et al.
Publicado: (2019)

Association of Attention-Deficit/Hyperactivity Disorder With Teenage Birth Among Women and Girls in Sweden
por: Skoglund, Charlotte, et al.
Publicado: (2019)

Overdiagnosis of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Systematic Scoping Review
por: Kazda, Luise, et al.
Publicado: (2021)

Association Between Periconceptional Weight of Maternal Grandmothers and Attention-Deficit/Hyperactivity Disorder in Grandchildren
por: Yim, Gyeyoon, et al.
Publicado: (2021)

Association of Prenatal Exposure to Benzodiazepines With Development of Autism Spectrum and Attention-Deficit/Hyperactivity Disorders
por: Chen, Vincent Chin-Hung, et al.
Publicado: (2022)

Motor Vehicle Crash Risk in Older Adult Drivers With Attention-Deficit/Hyperactivity Disorder
por: Liu, Yuxin, et al.
Publicado: (2023)

Prevalence of obesity in attention-deficit/hyperactivity disorder: study protocol for a systematic review and meta-analysis
por: Cortese, Samuele, et al.
Publicado: (2014)

Effects of melatonin in children with attention-deficit/hyperactivity disorder with sleep disorders after methylphenidate treatment
por: Masi, Gabriele, et al.
Publicado: (2019)

DRD4 48 bp multiallelic variants as age-population-specific biomarkers in attention-deficit/hyperactivity disorder
por: Bonvicini, Cristian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mu0vj7cr7hn6j59o18o3ipv251